Titan Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) announced today that company President Sunil Bhonsle will present during the 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010 at 2:00 p.m. ET. The presentation will be webcast from the Waldorf-Astoria Hotel in New York, NY.
To access the presentation via the Web, please go to the web site at www.titanpharm.com or at http://www.veracast.com/webcasts/bio/ceoinvestor2010/03113334.cfm. A replay of the webcast will be made available approximately 24 hours after the live presentation and the replay will be archived for 14 days.
About Titan Pharmaceuticals
For information concerning Titan Pharmaceuticals, Inc., please visit the Company's website at www.titanpharm.com.
The press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the Company's development program and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in development, testing, regulatory approval, production and marketing of the Company's drug candidates, adverse side effects or inadequate therapeutic efficacy of the Company's drug candidates that could slow or prevent product development or commercialization, the uncertainty of patent protection for the Company's intellectual property or trade secrets, and the Company's ability to obtain additional financing. Such statements are based on management's current expectations, but actual results may differ materially due to various factors, including those risks and uncertainties mentioned or referred to in this press release.
CONTACT: Titan Pharmaceuticals, Inc. Sunil Bhonsle, 650-244-4990 President
SOURCE Titan Pharmaceuticals, Inc.
Released February 4, 2010